SCHEMBL21332541

SCHEMBL21332541

O=C(NCCc1ccc(Oc2cccc(-c3ccncc3)c2)cc1)c1c(O)cc(O)cc1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.43
HIF1A Q16665 3/20 0.42
AURKA O14965 1/20 0.41
RAB9A P51151 1/20 0.41
MAPT P10636 1/20 0.41
GLI1 P08151 1/20 0.40
GLI2 P10070 1/20 0.40
LMNA P02545 1/20 0.40
CYP3A4 P08684 1/20 0.40
HTT P42858 1/20 0.40
MMP13 P45452 1/20 0.40
MAPK14 Q16539 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40
PLAAT3 P53816 1/20 0.40
PLAAT5 Q96KN8 1/20 0.40
PLAAT2 Q9NWW9 1/20 0.40
PLAAT4 Q9UL19 1/20 0.40
KMT2A Q03164 1/20 0.40
PTGIR P43119 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21332569 0.92 HIF1A (0.44) HIF1ARAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL21332709 0.88 RAB9A (0.46) HIF1ARAB9ALMNACYP3A4HTT
SCHEMBL21345753 0.84 KMT2A (0.50) HIF1ARAB9AMAPTSMN1; SMN2KMT2A
SCHEMBL21332776 0.83 PLAAT3 (0.55) RAB9AMAPTGLI1GLI2SMN1; SMN2
SCHEMBL21332561 0.83 KMT2A (0.53) RAB9AMAPTHTTMMP13SMN1; SMN2
SCHEMBL21333665 0.82 LTA4H (0.50) HIF1ARAB9AMAPTGLI1GLI2
SCHEMBL21346280 0.81 KMT2A (0.40) HIF1APLAAT3PLAAT5PLAAT2PLAAT4
SCHEMBL21332630 0.79 SLC5A1 (0.42) MAPTLMNACYP3A4PLAAT3PLAAT5
SCHEMBL21332469 0.78 SLC5A1 (0.61) RAB9AMAPTLMNASMN1; SMN2KMT2A
SCHEMBL21332514 0.78 LTA4H (0.55) RAB9AMAPTSMN1; SMN2EPHX2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11572337-B2 Antibacterial agents: arylalkylcarboxamido phloroglucinols RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2023-02-07 US disclosed
US-11572337-B2 Antibacterial agents: arylalkylcarboxamido phloroglucinols RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2023-02-07 US disclosed
US-20210017126-A1 Antibacterial Agents: Arylalkylcarboxamido Phloroglucinols RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2021-01-21 US disclosed
US-20210017126-A1 Antibacterial Agents: Arylalkylcarboxamido Phloroglucinols RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2021-01-21 US disclosed
WO-2019173507-A1 ANTIBACTERIAL AGENTS : ARYLALKYLCARBOXAMIDO PHLOROGLUCINOLS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2019-09-12 WO disclosed
WO-2019173507-A1 ANTIBACTERIAL AGENTS : ARYLALKYLCARBOXAMIDO PHLOROGLUCINOLS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2019-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11572337-B2 Antibacterial agents: arylalkylcarboxamido phloroglucinols RNGTT, FBL, POLR1C EPHX1 4224/4885HIF1A 2639/4885AURKA 2816/4885
US-20210017126-A1 Antibacterial Agents: Arylalkylcarboxamido Phloroglucinols RNGTT, FBL, POLR1C EPHX1 4224/4885HIF1A 2639/4885AURKA 2816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.